Concepedia

Publication | Open Access

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients

DOIFull Paper Access

84

Citations

25

References

2018

Year

Kohei Shitara, Takeharu Yamanaka, Tadamichi Denda, Yasushi Tsuji, Katsunori Shinozaki, Yoshito Komatsu, Y. Kobayashi, Junji Furuse, Hiroyuki Okuda, Masako Asayama,
Annals of Oncology

Abstract

The therapeutic sequence of regorafenib followed by cetuximab suggests a longer OS than the current standard sequence.

References

YearCitations

Page 1